Antibody Discovery News and Research

RSS

We are excited to release our latest software update with new Cyto-Mine functionalities!

The Cyto-Mine Studio Suite contains a collection of software to allow Cyto-Mine operation and data acquisition.

From Sphere Fluidics 16 Oct 2019

BioStreamline: Streamlining the development of next generation biotherapeutics

A collaboration to streamline the development of cost-effective next generation biotherapeutics will host a dissemination event at CPI.

From Sphere Fluidics 16 Oct 2019

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics, announced that is has closed a $2 million (circa £1.5 million) investment round.

From Sphere Fluidics 16 Oct 2019

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics, and Peak Analysis and Automation, will collaborate to offer automated micro-plate handling capabilities for single cell analysis.

From Sphere Fluidics 16 Oct 2019

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

We are delighted to announce that Cyto-Mine is one of the winners of The Scientist 2018 Top 10 Innovations!

From Sphere Fluidics 16 Oct 2019

Oxford Genetics unveils OXGENE brand

Oxford Genetics Ltd announces the launch of its brand OXGENE™. The new brand articulates the company’s powerful ability to combine highly innovative science with an engineering approach to custom solutions for biotechnology.

From OXGENE 11 Sep 2019

Rapid European adoption of Carterra’s LSA platform fuels expansion

Carterra Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.

From Carterra Inc. 16 Aug 2019

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS Limited, a leader in antibody discovery and optimization of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimization of human antibodies for use as biotherapeutics.

From FairJourney Biologics 31 Jul 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019.

25 Mar 2019

AvantGen and ACROBiosystems sign vendor agreement

AvantGen Inc., a world-leading CRO for human and rabbit antibody discovery and optimization, and ACROBiosystems Inc., a global biotech company specializing in recombinant protein technology jointly announced the signing of a preferred vendor agreement between the parties.

From ACROBiosystems 7 Mar 2019

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics announced today that is has closed a $2 million (circa £1.5 million) investment round.

From Society for Laboratory Automation and Screening (SLAS) 30 Jan 2019

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation, a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis.

30 Jan 2019

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular, the industry leader in the discovery of monoclonal antibodies against membrane proteins, and Merus N.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that they have entered into a collaboration on multiple undisclosed targets.

12 Dec 2018

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can "neutralize" the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.

21 Nov 2018

Antibody Screening Tools; Improving Workflows

Antibody screening tools have exponentially increased the rate that candidates can be screened, multiplexing will increase processing to thousands per hour.¬

From Sartorius 9 Oct 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic antibodies targeting undisclosed targets for use in the treatment of cancers.

5 Jun 2018

Oxford University Press and Chinese Antibody Society partner to launch Antibody Therapeutics

Oxford University Press and the Chinese Antibody Society are pleased to announce their new partnership to launch the journal Antibody Therapeutics this spring.

9 May 2018

Antibody Discovery News and Research

We are excited to release our latest software update with new Cyto-Mine functionalities!

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

Oxford Genetics unveils OXGENE brand

Rapid European adoption of Carterra’s LSA platform fuels expansion

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

AvantGen and ACROBiosystems sign vendor agreement

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Antibody Screening Tools; Improving Workflows

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

Oxford University Press and Chinese Antibody Society partner to launch Antibody Therapeutics

Immunology eBook

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News